Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




ADLM 2026 Unites Laboratory Experts Around Emerging Diagnostic Technologies

By LabMedica International staff writers
Posted on 31 Jul 2026

The Association for Diagnostics & Laboratory Medicine (ADLM) brought together nearly 17,000 laboratory professionals for its 2026 Annual Scientific Meeting & Clinical Lab Expo, held July 26–30 in Anaheim, California. More...

Across five days, the event highlighted advances in diagnostic research and technology addressing diabetes, space medicine, neurodegenerative disease, cancer screening, laboratory automation, and other areas of healthcare.

The scientific program featured plenary presentations from experts working across clinical research and laboratory medicine. Opening speaker Dr. David M. Nathan, recipient of the 2026 Wallace H. Coulter Lectureship Award, reflected on five decades of diabetes research and emphasized the importance of sustained collaboration and federal support.

On Monday, Dr. Kathleen McMonigal of the NASA Johnson Space Center Clinical Laboratory examined how changes in gravity affect human physiology and discussed laboratory strategies for monitoring astronaut health during future lunar and deep-space missions. The following day, Dr. Elizabeth Head of the University of California, Irvine, presented research into interventions that could delay or prevent Alzheimer’s disease among people with Down syndrome, who face a heightened risk of developing the condition.

Other plenary sessions focused on advances in cancer diagnosis and prevention. On Wednesday, Dr. Leeya Pinder of the University of Cincinnati discussed developments in cervical cancer screening and their potential to improve healthcare equity. Closing speaker Dr. Arun Wiita of the University of California, San Francisco, described how mass spectrometry is being used to identify improved biomarkers and treatment strategies for blood cancers.

Innovation also took center stage through the ADLM Disruptive Technology Award competition, where emerging companies presented diagnostic technologies intended to improve access to accurate testing. Kompass Diagnostics received the 2026 award for IDA, its rapid multimodal electrical transduction platform.

The Clinical Lab Expo featured 700 exhibitors across 308,611 net square feet of show space. Companies displayed technologies spanning artificial intelligence, clinical microbiology, molecular diagnostics, laboratory automation, point-of-care testing, mass spectrometry, and other areas of laboratory medicine.

Through its scientific sessions, product demonstrations, and industry presentations, ADLM 2026 underscored the central role of clinical laboratories in disease detection, patient management, public health, and healthcare innovation. 

“This year’s meeting brought together clinical laboratory medicine experts from all over the world, highlighting our field’s vital — and expanding — role in driving healthcare forward,” said ADLM CEO Melanie J. Wells.

“From designing sophisticated diagnostics for space travelers to mobile testing solutions that widen access to healthcare here on Earth — and conducting a diverse array of research addressing major global health challenges like diabetes, Alzheimer’s, and cancer — clinical labs are the incubators for some of the greatest minds in medicine today. I hope that every attendee of ADLM 2026 feels the same sense of pride I do from witnessing firsthand our mighty collective impact,” Wells said.

The organization’s next annual meeting, ADLM 2027 will be held in Chicago from July 25-29, 2027.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.